The biotechnology market is entering a new growth phase, driven by the convergence of genomic science, artificial intelligence, and precision medicine.

The upcoming EU Biotech Act may be more prominently focused on health. But it will also significantly impact food and food ...

UD chemical engineer wins the AIChE Langer Prize for efforts to harness biology to manage plastic waste sustainably ...

(MENAFN- GlobeNewsWire - Nasdaq) Nanoparticle technology offers significant opportunities in pharma and biomedicine, particularly in drug delivery, diagnostics, and therapeutic innovations. With ...

After walking away from cell therapy and narrowing its focus to just three modalities, Takeda is doubling down on its remaining strategic commitment by reupping a pact with AI drug designer Nabla Bio.

Shares of Spruce Biosciences, Inc. (NASDAQ:SPRB) are surging Monday after the biotech company shared an important regulatory update about one of its therapy treatments. What To Know: Spruce ...

Shares of the microcap biotech Spruce Biosciences just had their best day on record after it said the Food and Drug Administration had granted it a special designation that would allow its ...

A company’s plan to edit the genomes of human embryos worries some researchers — but it might reflect the changing attitudes ...

Lumen Biosciences Brian Finrow breaks down Chinas biotech playbook and explores ways the U.S. can adapt it for its own continued success.

Federal regulators are trying to make it easier to develop cheaper alternatives to powerful drugs that many Americans depend ...

The U.S. government is divesting from mRNA vaccines, but will other uses of the technology be spared? In a time of ...